Hematology TimesStudy elucidates MYC’s role in T-ALLMarch 11, 2016Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesCompound could treat T-ALL subtypeMarch 9, 2016Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesChanges in chromosome structure contribute to T-ALL, other cancersMarch 4, 2016Leukemia, Myelodysplasia, TransplantationALL
Hematology NewsChildren’s cancer survival steadily increasingMarch 1, 2016AMLPediatricsALLCNS/Brain CancerLymphoma & Plasma Cell DisordersPatient & Survivor Care
Hematology TimesPre-labor cesarean delivery linked to ALLFebruary 29, 2016Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesTeam identifies potential target for T-ALL therapyFebruary 26, 2016Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesPoverty tied to early relapse in kids with ALLFebruary 24, 2016Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesTargeting EZH2 to treat ETP-ALLFebruary 19, 2016Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesGene variants linked to drug intoleranceFebruary 16, 2016Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesChemo linked to long-term learning problems in ALL survivorsFebruary 12, 2016Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesDendritic cells appear to promote T-ALLFebruary 11, 2016Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesNew insight into Ph-like ALL could lead to new treatmentFebruary 9, 2016Leukemia, Myelodysplasia, TransplantationALL
Hematology NewsSurvivors of childhood ALL show significant attention problemsFebruary 8, 2016ALLLeukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Hematology TimesInduction ALL treatment can cause bone lossFebruary 7, 2016Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesGeneric imatinib launched with savings programFebruary 4, 2016CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPediatricsPharmacyALLMyelodysplastic Syndrome